ALB and stroke disorder: Dash et al. (2020) explores the role of serum albumin as a prognostic marker in AIS, assessing its correlation with stroke severity (NIHSS) and outcomes at 1 week and 3 months (mRS) with a sample Size of 100 patients (58% male, 42% female; mean age 65±8.160 years).19 Our study is cross-sectional with outcome measures focused on discharge, while Dash et al. (2020) is prospective with extended follow-up, potentially allowing for the observation of trends over time.